Congress Materials

Medical Information
India
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for India Healthcare Professionals. Would you like to proceed?

I am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
SelectI am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
I am a patient/caregiver residing in IndiaNo, go back to the patient portal
SelectI am a patient/caregiver residing in IndiaNo, go back to the patient portal
Non-India residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Oral Presentation
Grivas P, Bellmunt J, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, Loriot Y, Sridhar SS, Tsuchiya N, Sternberg CN, Aragon-Ching JB, Petrylak DP, Blake-Haskins JA, Laliberte RJ, Wang J, Costa N, Powles T May 13, 2022 AUA 2022 Urothelial Cancer

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Long-Term Follow-Up Results From the JAVELIN Bladder 100 Trial

View Presentation View Abstract Plain Language Summary
Poster
Mehlhaff B, Shore ND, George DJ, Cookson MS, Saltzstein DR, Tutrone R, Bailen JL, Brown B, Langenberg AGM, Fallick M, Lu S, Hanson S, Tombal B, Saad F May 14, 2022 AUA 2022 Prostate Cancer

Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer: Detailed Safety Analysis From the Randomized Phase 3 HERO Study

View Presentation View Abstract Plain Language Summary
Poster
Shore ND, Iguchi T, Villers A, Azad AA, Szmulewitz RZ, Holzbeierlein J, Alcaraz A, Alekseev B, Gomez-Veiga F, Rosbrook B, Lee H-J, Haas GP, Armstrong AJ, Stenzl A May 14, 2022 AUA 2022 Prostate Cancer

Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer Treated With Enzalutamide or Placebo Plus Androgen Deprivation Therapy who had Prior Local Therapy: Post Hoc Analysis of the Phase 3 ARCHES Trial

View Presentation View Abstract Plain Language Summary
Poster
Lowentritt B, Fallick M, Dufour R, Pruett J, Jiang T, Nwokeji E, Nagao M May 15, 2022 AUA 2022 Prostate Cancer

Evaluating Cardiovascular Risk in Men Starting Androgen Deprivation Therapy for Prostate Cancer

View Presentation View Abstract Plain Language Summary
Oral Presentation
Bailen JL, Saad F, George DJ, Mehlhaff B, Cookson MS, Saltzstein DR, Tutrone R, Brown B, Langenberg AGM, Lu S, Lee J, Hanson S,  Tombal B, Shore ND May 15, 2022 AUA 2022 Prostate Cancer

Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer: Pooled Safety Analyses from Randomized Controlled Studies

View Presentation View Abstract Plain Language Summary